BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2018
View Archived Issues
AD brains have splicing problem
Read More
Protecting cartilage in arthritis
Read More
Insm1 keeps hair cells in 'n' out
Read More
Amgen begins first-in-human study of AMG-427 in relapsed or refractory AML
Read More
Modest improvements to visual acuity observed following retinal gene therapy for choroideremia
Read More
TLR9-targeted oligonucleotide NF-KappaB inhibitor developed for B-cell lymphoma
Read More
Evobrutinib shows reduction in disease activity in patients with relapsing MS
Read More
Abide Therapeutics initiates phase II study of ABX-1431 in Tourette syndrome
Read More
Patient recruitment ongoing in long-term phase III study of SK-1403
Read More
Mouse model mimics human tumors for testing MCL-1 inhibitors
Read More
First results presented for [177Lu]Lu-DOTA(ZOL) in patients with osteoblastic metastases
Read More
Lianyungang Ruzhong Pharmaceutical Co. and collaborators describe new IDO/TDO inhibitors
Read More
Heat shock protein 90 inhibitors discovered at Taipei Medical University
Read More
Evotec and Ferring enter strategic research alliance to treat fertility and gynecological conditions
Read More
Universite Paris Descartes and collaborators patent GRB14/insulin receptor interaction inhibitors
Read More
Eiger's phase II study of ubenimex in lower leg lymphedema does not meet endpoints
Read More
Shanghai Hengrui Pharmaceutical Co., Jiangsu Hengrui Medicine Co. discover TGFBR1 inhibitors
Read More
STING modulators identified at Boehringer Ingelheim
Read More
Phase II study of avexitide in post-bariatric hypoglycemia meets key endpoints
Read More
Zhejiang Hisun Pharmaceutical Co. patents acetyl-CoA carboxylase inhibitors
Read More
Phase III SUNRISE 2 trial of lemborexant in insomnia meets key endpoints
Read More
OCLI-070 inhibits osteoclast differentiation in ligature-induced experimental osteolysis
Read More
FDA approves Talzenna for germline BRCA-mutated HER2-negative breast cancer
Read More
Allergan plans ubrogepant NDA filing following successful outcome of safety studies
Read More